Apotex is Canada’s largest home-grown pharmaceutical company, with a broad portfolio of generic medicines, biosimilars, innovative branded products and consumer health items. It manufactures and supplies affordable medicines across Canada, the United States, Mexico and India, serving patients and healthcare systems that depend on high-volume, lower-cost alternatives to originator drugs. The company is known for a deep product slate—hundreds of medicines—and for expanding access through regulatory firsts in generics.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2024 | 2,940.4 | — | -146.9 | — |
| 2025 | 3,349.7 | 13.9% | 151.7 | — |
| 2026 | 3,490.8 | 4.2% | 373.8 | 146.4% |
All markets — KeepWinning global stock screener
Other companies on Toronto (TSX): K92 Mining Inc. (KNT), Colliers International Group Inc. (CIGI), Groupe Dynamite Inc. (GRGD), Chartwell Retirement Residences (CSH UN), Exchange Income Corporation (EIF), BlackBerry Limited (BB)